Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalent Inc
(NY:
CTLT
)
60.29
+0.43 (+0.72%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Catalent Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
January 25, 2024
From
Catalent, Inc.
Via
Business Wire
Analyst Expectations For Catalent's Future
January 25, 2024
Via
Benzinga
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
January 19, 2024
2023 was a historical milestone for S&P 500 as it once again surpassed record highs, largely due to tech giants and artificial intelligence. Top gainers were NVIDIA, Meta Platforms, and AMD.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
These 9 Stocks Are Running To Start 2024
January 14, 2024
The S&P 500 is up just 0.2% in 2024. These stocks are off to a strong start.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
What Happened With Caltalent Stock?
December 19, 2023
Catalent, Inc. (NYSE: CTLT) shares traded higher on Tuesday. Following losses at the end of October, the stock has rebounded over the past month.
Via
Benzinga
What 9 Analyst Ratings Have To Say About Catalent
November 16, 2023
Via
Benzinga
Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Catalent, Inc.
Via
Business Wire
Catalent Announces Closing of Incremental Term Loans
December 19, 2023
From
Catalent, Inc.
Via
Business Wire
Catalent Regains Compliance with NYSE Continued Listing Standards
December 15, 2023
From
Catalent, Inc.
Via
Business Wire
Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'
November 30, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc.
Via
Benzinga
Recap: Catalent Q1 Earnings
November 15, 2023
Via
Benzinga
Preview: Catalent's Earnings
November 14, 2023
Via
Benzinga
Analyst Ratings for Catalent
September 29, 2023
Via
Benzinga
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
November 16, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
November 15, 2023
Catalent Inc's (NYSE: CTLT) Q1 FY24 revenue of $982 million decreased 4% as reported, or 6%, in constant currency, beating the
Via
Benzinga
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
November 15, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
November 15, 2023
U.S. stocks could build on the momentum they picked up on Tuesday following the release of benign inflation data. Traders get to digest another batch of economic data on producer price inflation,...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
November 15, 2023
From
Catalent, Inc.
Via
Business Wire
Sotera Health Appoints Karen Flynn to Board of Directors
November 13, 2023
From
Sotera Health Services, LLC
Via
GlobeNewswire
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
November 07, 2023
The company's recently FDA-approved gene therapy is struggling to gain traction.
Via
Investor's Business Daily
What's Going On With Biotech Contract Service Firm Catalent Stock Today?
October 31, 2023
Catalent Inc (NYSE: CTLT) shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc (NASDAQ: SRPT) on the back of disappointing data from a pivotal gene therapy trial.
Via
Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Catalent, Inc. Announces First Quarter Fiscal Year 2024 Earnings Conference Webcast
October 31, 2023
From
Catalent, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 31, 2023
It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
Via
Benzinga
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
October 09, 2023
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)...
Via
Benzinga
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Catalent Appoints David McErlane as Biologics Segment Leader
September 18, 2023
From
Catalent, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.